A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China.
Du J, Fang B, Li J, Jin J, Wang S, Zou D, Cai Z, Wang H, Hu J, Li W, Fu C, Shao Z, Xia Z, Liu P, Niu T, Tang ET, Kimball AS, Hou J, Chen W.
Du J, et al. Among authors: tang et.
Int J Hematol. 2021 Mar;113(3):422-429. doi: 10.1007/s12185-020-03044-z. Epub 2021 Jan 3.
Int J Hematol. 2021.
PMID: 33389656